Bismuth quadruple therapy

DRUG6 trials

Sponsors

Kaohsiung Veterans General Hospital., National Cancer Center, Korea, National Taiwan University Hospital, Ying HUANG, Zhongda Hospital

Conditions

Family History of Stomach CancerH. Pylori InfectionHelicobacterHelicobacter InfectionsHelicobacter Pylori InfectionPeptic Ulcer

Phase 3

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

CompletedNCT02557932

National Cancer Center, KoreaFamily History of Stomach Cancer, Helicobacter Pylori Infection

Start: 2015-09-30End: 2019-09-28Updated: 2020-04-08

Phase 4

Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication

National Taiwan University HospitalHelicobacter

Start: 2015-09-30End: 2019-12-31Target: 620Updated: 2017-05-17

Unknown Phase

Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication

CompletedNCT02541864

Kaohsiung Veterans General Hospital.Helicobacter Pylori Infection

Start: 2013-07-31End: 2015-08-31Updated: 2017-11-24

A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

RecruitingNCT03365609

Ying HUANGHelicobacter Infections

Start: 2017-09-20End: 2025-12-31Target: 1440Updated: 2025-02-28

Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection

Not yet recruitingNCT07012785

Zhongda HospitalH. Pylori Infection

Start: 2025-06-30End: 2025-12-31Target: 208Updated: 2025-06-10

Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

RecruitingNCT07260006

Can Tho University of Medicine and PharmacyHelicobacter Pylori Infection, Peptic Ulcer

Start: 2024-10-01End: 2026-05-30Target: 80Updated: 2025-12-02

Related Papers

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial.

2021-03-0214 citations

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial.

2018-09-0123 citations

A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance

Antimicrobial Agents and Chemotherapy2017-08-1535 citations